ImmTOR-IL

N/A

Report date: 2025/06/11 10:17:43

Base Information

Drug NameImmTOR-IL
Drug Alias NameImmTOR + IL
ClassificationBiologics
Mechanisms of ActionInterleukin-2 receptor agonistsImmunomodulatorsRegulatory T-lymphocytes modulators
TargetsInterleukin-2 receptor
Therapy Area/IndicationsAutoimmune DiseasesImmune System DiseasesLiver Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSelecta Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesCartesian Therapeutics IncCyrus Biotechnology Inc
Inactive CompaniesSelecta Biosciences Inc
Active IndicationsAutoimmune DiseasesLiver Diseases
Inactive IndicationsImmune System Diseases

Other Information

ATC CodeN/A
Related LinksN/A